Oxford Immunotec Global PLC Business Finance Contracts & Agreements
34 Contracts & Agreements
- Exchange Agreements (20 contracts)
- Guarantee Agreements (1)
- Loan Agreements (2)
- Purchase Agreements (5)
- Registration Rights Agreements (1)
- Share Agreements (1)
- Underwriting Agreements (2)
- Warrant Agreements (2)
- Third Amendment to Purchase Agreement between Mabtech AB and Oxford Immunotec Limited, dated June 17, 2020 (Filed With SEC on August 4, 2020)
- Amendment to the Agreement to Purchase Test Kits and Accessories between Oxford Immunotec USA, Inc. and Quest Diagnostics Incorporated dated June 12, 2019 (Filed With SEC on June 14, 2019)
- Limited Liability Company Interest Purchase Agreement, dated September 25, 2018, by and among Oxford Immunotec Global PLC, Quest Diagnostics Incorporated, Oxford Immunotec Limited... (Filed With SEC on September 25, 2018)
- Second Amendment to Purchase Agreement between Mabtech AB and Oxford Immunotec Limited dated November 17, 2017 (Filed With SEC on February 27, 2018)
- OXFORD IMMUNOTEC GLOBAL PLC 2,500,000 Ordinary Shares Underwriting Agreement (Filed With SEC on August 18, 2017)
- CREDIT, SECURITY AND GUARANTY AGREEMENT (TERM LOAN) dated as of October 4, 2016 by and among OXFORD IMMUNOTEC, INC., as Borrower, OXFORD IMMUNOTEC GLOBAL PLC and OXFORD IMMUNOTEC... (Filed With SEC on October 7, 2016)
- Purchase Agreement between Imugen, Inc. and Oxford Immunotec, Inc. Dated as of June 23, 2016 TABLE OF CONTENTS (Filed With SEC on July 6, 2016)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on May 4, 2016)
- FORM OF AMENDMENT TO OFFICER RESTRICTED SHARE AWARD (Filed With SEC on March 1, 2016)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on August 4, 2015)
- OXFORD IMMUNOTEC GLOBAL PLC [] Ordinary Shares Underwriting Agreement (Filed With SEC on November 14, 2013)
- REGISTRATIONRIGHTS AGREEMENT dated [ ], 2013 by and among Oxford Immunotec Global PLC and certain shareholders (Filed With SEC on November 8, 2013)
- Signature(s) Guaranteed:Medallion Guarantee Stamp (Filed With SEC on November 8, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on November 5, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on November 5, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on November 5, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 25, 2013)
- OXFORD IMMUNOTEC, INC. LOAN ANDSECURITY AGREEMENT (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 15, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 15, 2013)
